News

News

                        Array
(
    [0] => stdClass Object
        (
            [id] => 1109
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 1-compressed_(3).jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2023-07-13
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2023-07-13 15:51:22
            [updated_time] => 2023-08-22 14:48:34
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => gentis-tiep-doan-chuyen-gia-danh-gia-giam-sat-va-mo-rong-tieu-chuan-iso-151892012
            [title] => GENTIS receives a delegation of Auditors to monitor and expand ISO 15189:2012
            [description] => On July 10 - 12, 2023, GENTIS was honored to welcome a delegation of Auditors from the Office of Quality Accreditation (BoA) to conduct the NIPT test monitoring assessment and the criteria to expand the package. NIPT tests (such as PGT-A, Thalassemia, ...) according to ISO 15189:2012 for GENTIS International Laboratories. This event marked the development of the capacity and quality assurance management system in GENTIS testing operations.

            [content] => 

The meeting had the presence of Ms. Nguyen Hong Nhung - Quality Assessor, Quality Accreditation Office as Head of the Evaluation Team and Mr. Duong Quoc Chinh - Hematology Technical Evaluation Specialist, Institute of Hematology Transfusion. Central Blood and GENTIS leadership representatives, all staff of GENTIS international laboratory and ISO department of GENTIS.

According to the assessment program, from July 10 to 12, 2023, the assessment team worked directly at the office and the GENTIS International Laboratory to conduct surveillance assessment of NIPT testing, the indicators. extended to NIPT test packages according to ISO 15189:2012.

The audit team examined the records related to the application and development of the quality management system according to the ISO 15189:2012 certificate issued for the NIPT test. At the same time, extensive evaluation for NIPT test packages meets ISO 15189:2012 standards. As follows:
• Management requirements (4.1 – 4.15)
• Technical requirements (5.1 – 5.10)
• Management requirements (4.3; 4.9; 4.13)
• Technical requirements (5.1 – 5.10)
• Observing test indicators
• Observe sampling, transport and receiving samples.
• Observe the result reporting system
The meeting took place in an atmosphere of urgency and seriousness. At the end of the meeting, Ms. Nguyen Hong Nhung - Head of the assessment team made some comments as follows: GENTIS complies well with the standard requirements of the system.
Through the evaluation of NIPT testing supervision and the expanded criteria for NIPT test packages according to ISO 15189:2012, GENTIS has demonstrated to the expert team its ability to fully satisfy in quantity and quality. quality standards including facilities, personnel, equipment, quality management system in accordance with the regulations of the Laboratory.
The evaluation and supervision of NIPT testing and the expanded criteria for NIPT test packages according to ISO 15189:2012 standard in order to improve the capacity of GENTIS International Laboratories, ensure better service quality for customers. The final conclusion of the surveillance and quota expansion was that the GENTIS International Laboratory met the requirements for maintaining accreditation according to ISO 15189:2012.

On behalf of GENTIS Company, Mr. Nguyen Quang Vinh - Director of the Testing Center expressed his thanks and received the comments of the evaluation team so that GENTIS could perfect, as well as further develop the system, to improve the quality of the work. working in the areas of operation of the GENTIS International Laboratory.

[content_more] => [meta_title] => GENTIS receives a delegation of Auditors to monitor and expand ISO 15189:2012 [meta_description] => [meta_keyword] => [thumbnail_alt] => [post_id] => 1109 [category_id] => 4 ) [1] => stdClass Object ( [id] => 1108 [id_crawler] => [category_product] => NULL [thumbnail] => lop-hoc-tien-san-bv-lac-viet-2.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2023-07-11 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-07-11 13:11:21 [updated_time] => 2023-08-22 14:53:07 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => gentis-dong-hanh-cung-lop-hoc-tien-san-thang-7-tai-bv-huu-nghi-lac-viet [title] => GENTIS accompanies the July Prenatal Class at Lac Viet Friendship Hospital [description] => On the morning of July 9, GENTIS and Lac Viet Friendship Hospital jointly organized an extremely meaningful July antenatal class with the theme: "Common problems of postpartum women - Recognizing and handling ". The class has brought pregnant mothers useful and practical knowledge after giving birth. [content] =>

As a topic of interest to many pregnant women, the July antenatal class at Lac Viet Friendship Hospital attracted more than 50 parents in the area to participate and experience and accumulate knowledge. Lecturer at the class is Master of Resident Doctor Nguyen Thi Hang - Department of Obstetrics and Gynecology, Lac Viet Friendship Hospital. GENTIS is honored to have the participation of Ms. Le Thi Hong Nhung - Product Management Department.

Here, pregnant mothers were shared by Dr. Hang about safe motherhood, common problems after giving birth, postpartum care, etc. The program was lively and received very positive feedback from parents.
The July prenatal class at Lac Viet Friendship Hospital becomes a place to share worries during pregnancy, childbirth, postpartum and provide a lot of knowledge for pregnant mothers. The class is not only for pregnant women but also attracts many fathers, grandmothers and grandmothers to participate because taking care of a new born baby is the task of many people. Through the antenatal class in July, not only the mother but also the father is equipped with basic knowledge of postpartum knowledge.
Not only that, parents also listened to Ms. Le Thi Hong Nhung - Product Management Department of GENTIS Company share about NBS testing. In Vietnam, the NBS program with regional projects has been implemented since 1998. In 2015, NBS was deployed nationwide with 3 diseases: congenital hypothyroidism, congenital adrenal hyperplasia and G6PD enzyme deficiency. In recent years, NBS has expanded to more groups of diseases such as congenital metabolic disorders, abnormal red blood cells, galactosemia, phenylketouria...

This is an important test to help detect congenital pathology early for timely treatment, to avoid disease progression and difficulty in treatment, as well as to reduce costs for later treatment sessions or become a burden for families and friends. society.
In addition, expectant mothers are also asked questions throughout the process from pregnancy, delivery to the postpartum period. In particular, pregnant mothers who register for the Maternity Service Package when participating in the July antenatal class at Lac Viet Friendship Hospital will receive a FREE GENTIS package of NBS heel blood collection to screen for 5 diseases for their baby.

GENTIS is always proud to be a pioneer in the field of genetic analysis; We are always at the forefront of technological innovation with the desire to bring safe and scientific test packages. Hopefully in the future, GENTIS will always receive the trust and support from everyone.

[content_more] => [meta_title] => GENTIS accompanies the July Prenatal Class at Lac Viet Friendship Hospital [meta_description] => [meta_keyword] => [thumbnail_alt] => [post_id] => 1108 [category_id] => 4 ) [2] => stdClass Object ( [id] => 1105 [id_crawler] => [category_product] => NULL [thumbnail] => bv-thanh-nhan.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2023-07-05 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-07-05 09:27:14 [updated_time] => 2023-08-22 16:25:09 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => gentis-trao-100-phan-qua-cho-me-bau-trong-chuong-trinh-cho-con-yeu-khoi-dau-ven-toan-tai-bv-thanh-nhan [title] => GENTIS gives 100 gifts to pregnant mothers in the program "Give your baby a perfect start" at Thanh Nhan Hospital [description] => The program "Give your baby a perfect start" took place from June 1, 2023 - July 1, 2023, organized by GENTIS in collaboration with the Department of Obstetrics and Gynecology 2 - Thanh Nhan Hospital and successfully took place. GENTIS is honored to be the main sponsor, accompanying this program. [content] =>

More than 100 sets of newborn clothes have been hand-delivered by GENTIS and Thanh Nhan Hospital to pregnant women who registered for examination and birth at the Department of Obstetrics and Gynecology 2 - Thanh Nhan Hospital. This is a small gift GENTIS wants to give to pregnant mothers as a deep gratitude for using the NBS testing service. Most importantly, GENTIS wants to join hands with Thanh Nhan Hospital to gradually popularize NBS testing to people across the country.

The program "Give your baby a perfect start" is an event in the series of campaigns in cooperation with GENTIS's Thanh Nhan Hospital. With the desire to accompany doctors and experts to provide comprehensive health care for children and contribute to improving the quality of Vietnam's population, GENTIS hopes that after this program, families have better understand the importance of having an NBS test as soon as a baby is born.

According to experts, newborn screening helps to detect congenital diseases early for timely treatment, avoid disease progression, difficult to treat as well as reduce costs for later treatment sessions or become a burden for patients, family and society. Currently, GENTIS is providing 3 packages of NBS testing, which are the 5 disease NBS package, the Hemoglobin disease NBS package and the 82 disease NBS package for mothers to freely choose.

It is noteworthy that the NBS test packages at GENTIS can now detect the following diseases: G6PD enzyme deficiency, Congenital hypothyroidism, Congenital adrenal hyperplasia, Phenylketonuria, Galactosemia; metabolic disorders and hemoglobin disease.
A special feature is the quick return of test results, thereby helping to improve the value of the test in early detection and timely treatment. With high-risk NBS results, Dr. BS Tran Thi Chi Mai - Head of Biochemistry Department of National Children's Hospital will read the results and advise, giving the next indication. In addition, GENTIS also provides genetic tests to help diagnose the results, help doctors give advice and prescribe the best treatment for children.

Once again, GENTIS would like to thank the Department of Obstetrics and Gynecology II - Thanh Nhan Hospital for accompanying this meaningful program! See you all at the next event!

[content_more] => [meta_title] => GENTIS gives 100 gifts to pregnant mothers in the program "Give your baby a perfect start" at Thanh [meta_description] => [meta_keyword] => [thumbnail_alt] => [post_id] => 1105 [category_id] => 4 ) [3] => stdClass Object ( [id] => 1101 [id_crawler] => [category_product] => NULL [thumbnail] => dsc01297-compressed.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2023-06-19 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-06-19 14:45:12 [updated_time] => 2023-08-22 16:37:30 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => gentis-tham-gia-hoi-nghi-san-phu-khoa-toan-quoc-2023-vago [title] => GENTIS participates in the 2023 National Congress of Obstetrics and Gynecology (VAGO) [description] => The 2023 National Congress of Obstetrics and Gynecology is a major annual event of the Vietnamese health sector, organized by the Vietnam Association of Obstetricians and Gynecologists (VAGO). The conference took place on the morning of June 15, 2023, attracting the participation of more than 500 national and international experts in obstetrics and gynecology, leading clinicians and technical experts. GENTIS is honored to provide the report data to MSc Nguyen Viet Quang (Director of the Center for Reproductive Support of the National Hospital of Obstetrics and Gynecology) with the topic: “Personalization and Optimization of the Embryo Transfer Window: ROLE SUPPORT OF GENE TESTING AND EFFICIENCY IN CLINICAL APPLICATION”. [content] =>

The 2023 National Congress of Obstetrics and Gynecology was held with the goal of exchanging experiences and presenting new scientific findings in the fields of health, prenatal diagnosis, gynecology, oncology, obstetrics, and support. fertility… Attending the conference were representatives of leaders of the Ministry of Health such as: Prof. Dr. Nguyen Viet Tien (Former Deputy Minister of Health, Chairman of the Vietnam Association of Obstetricians and Gynecologists); BS. Dinh Anh Tuan - Director of the Department of Maternal and Child Health, Ministry of Health; together with leading experts from FIGO, AOFOG, VAGO such as GS. Pisake Lumbiganon - President of AOFOG, Prof. Philippe Descamps - Vice President of the International Federation of Obstetrics and Gynecology (FIGO) and more than 500 delegates who are active in the field of obstetrics and gynecology come from major domestic and international hospitals and centers.

The conference took place in 2 days, June 15-16, 2023 with 9 thematic sessions, 5 satellite seminars and 49 attractive reports on important topics in the field of obstetrics and gynecology, typically:
• Interventional surgeries in assisted reproductive technology - Prof. Dr. Nguyen Viet Tien (Chairman of Vietnam Association of Obstetricians and Gynecologists)
• Research on cystic lymphatic malformations at the National Hospital of Obstetrics and Gynecology - Assoc. Prof. Dr. Tran Danh Cuong (Director of the National Hospital of Obstetrics and Gynecology, Standing Vice President of VAGO)
• WHO perinatal care for a positive birth experience - Prof Pisake Lumbiginon (AOFOG President)
• Short-term and long-term effects of cesarean section on women's health - Dr.U.D.P.Ratnasiri (MFM committee chair)
• Prevention of first caesarean section - Dr Rohana Haththotuwa (AOFOG Secretary)

Before the conference, the delegates participated in a course with the theme "For the sustainability of minimally invasive surgery: from basic to advanced" with the participation of leading experts in Vietnam and world. At the conference, the Symposium on Reproductive Support was interested by many doctors and experts. Especially the knowledge of new tests that are clinically effective for assisted reproductive treatment

At this discussion session, MSc Nguyen Viet Quang (Director of the Center for Reproductive Support of the National Hospital of Obstetrics and Gynecology) presented a report with the research topic: “Personalization and Optimization of the Embryo Transfer Window. : ROLE OF GENE TESTING AND EFFICIENCY IN CLINICAL APPLICATION”. This is one of the presentations that many delegates are interested in because of the urgency and practical application of the topic. GENTIS is honored to provide data reported to MSc Nguyen Viet Quang (Director of Center for Obstetrics and Gynecology, Central Obstetrics and Gynecology) in this topic.

️Genratest is a genotypic expression-based analytical test used to determine the optimal timing for embryo transfer (window period). Currently, the use of the Genratest Embryo Transfer Window test has been used in Vietnam and initially has had good signals.

In the world, there are many different views about the effectiveness of Genratest. However, according to the report of Ths.BS Viet Quang, there have been studies in Vietnam that have brought positive results for patients with failed implantation many times, coming from the research of Dr. Ly Thai Loc and Dr. partner:
• Pregnancy rates are raised to par with the population of patients without multiple implantation failures
• Expectation of live birth is higher than normal

 

GENTIS is honored to be the provider of Genratest test in Vietnam and is conducting many clinical studies to support doctors in assisted reproductive treatment. The tests of GENTIS promise to bring great significance in the diagnosis, treatment and development of obstetrics and gynecology in particular and the country's medicine in general. Once again, GENTIS would like to wish the National Congress of Obstetrics and Gynecology 2023 well.

[content_more] => [meta_title] => GENTIS participates in the 2023 National Congress of Obstetrics and Gynecology (VAGO) [meta_description] => [meta_keyword] => [thumbnail_alt] => [post_id] => 1101 [category_id] => 4 ) [4] => stdClass Object ( [id] => 1097 [id_crawler] => [category_product] => NULL [thumbnail] => pgt-m-2.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2023-06-09 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-06-09 13:17:43 [updated_time] => 2023-08-22 15:26:26 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => y-nghia-va-tam-quan-trong-cua-pgtm-voi-gia-dinh-mac-benh-di-truyen-de-sinh-con-khoe-manh [title] => Significance and importance of PGT-M for families with genetic diseases to have healthy children [description] => PGT-M is a test to detect genetic mutations that cause disease in embryos that are inherited from one parent or both parents before being selected for transfer into the uterus - a method to help mothers with in vitro fertilization (IVF) give birth to a healthy baby. Thereby improving the quality of embryo transfer and giving birth to healthy babies. [content] =>

1. What is the PGT-M test?

PGT-M is a pre-embryo transfer genetic test for monogenic inherited diseases. With this test, we can test the embryo's genome very early, helping to detect abnormal passages on a particular gene inherited from parents.
From there, the embryos that are homozygous for the disease gene will be removed before being transferred to the mother's uterus. The effectiveness of the PGT-M test has been shown to limit the number of babies born with thalassemia and the need to terminate the pregnancy mid-term when the fetus has severe anemia abnormalities.

Not only effective in diagnosing thalassemia, the PGT-M test also helps diagnose many other single-gene diseases in embryos such as X-linked genetic diseases, dystrophy Duchenne muscle, Hemophilia,... Moreover, in the future, this test is also aimed at treating siblings of children who have been born but have the disease.
In addition, the PGT-M test can diagnose the human leukocyte antigen (HLA) match of the embryo with the affected sibling. Stem cells from the cord blood of children born from embryos selected through PGT-M will help treat siblings with the disease.

2. Who should perform the PGT-M test?

The PGT-M test is ordered by the doctor in cases where there is a history of a husband or wife carrying the disease gene, or in the family there is an inherited disease caused by a gene mutation such as monodominant inherited diseases (eg. Huntington's disease), monogenic recessive diseases (eg, cystic fibrosis), chromosomal disorders (eg, numerical or structural abnormalities), sex-linked disorders (eg, Duchenne muscular dystrophy), predictors of cancer (cervical cancer, breast cancer, etc.) or determine HLA compatibility (to select embryos compatible with HLA antigens with siblings). have a disease that requires blood transfusion, marrow transplant. This child can later cure the disease, donate marrow for brother/sister).

For patients at risk of passing a genetic disease on to their children, PGT-M reduces the risk and increases the likelihood of having a healthy baby. Also avoid emotionally and ethically challenging decisions when deciding whether to terminate a pregnancy if the fetus has a genetic abnormality.
In clinical practice, PGT-M is often combined with the PGT-A/SR test to comprehensively assess embryo quality and improve the success rate of assisted reproduction methods. Patients with single-gene disorders are mostly young and have a good prognosis, but their risk of spontaneous abortion is still quite high. In recent years, many studies have reported that when embryos are combined with PGT-M and PGT-A screening, the pregnancy rate can increase from 45 to 68% and the rate of spontaneous abortion decreases from 15% to 15%. 5%.

In addition, the combination of PGT-A screening is appropriate for the majority of women undergoing IVF. All women are at risk of producing embryos with chromosomal abnormalities (trisomy 13, 18, 21), and as maternal age increases, the likelihood of embryos with chromosomal abnormalities increases. However, the PGT-A test can help women of all ages increase their chances of successful fertilization and embryo transfer.

3. How is the PGT-M test done?

Basically, to perform the PGT-M test, couples need to be assisted with IVF. The generated embryos will be raised to day 5.

With the eligible embryos on day 5 (blastocysts) will be biopsied (removing 3 - 5 embryonic cells from the cell area that will develop into the placenta later). Cell samples after biopsy will be applied special testing methods to detect disease-carrying genes.

With modern medicine, today, we can also perform the ASEM test on the embryo culture medium sample without the need for an embryo biopsy. With this technique, we do not need to worry about possible effects on the embryo during the biopsy.

4. The purpose of PGT-M for families with inherited diseases to have healthy children

According to research, the current infertility rate in Vietnam accounts for 7.7%, of which the causes are equal to men and women, accounting for 40% of each gender and 20% of unknown causes. The development and rapid progress of genetic engineering and technologies have greatly benefited the field of assisted reproduction right from the pre-implantation embryo stage.
The PGT method (pre-implantation embryo screening) has greatly contributed to the selection of the healthiest embryos before implantation in the uterus, increasing the chances of pregnancy, reducing the number of cycles of in vitro fertilization and the cost of pay. In addition, PGT-M is a test to identify abnormalities, single gene mutations associated with some genetic disease syndromes such as Thalassemia, Hemophilia, muscular atrophy, polycystic kidney, RETT syndrome,... PGT -M is indicated for couples who carry a disease-causing mutation and are at high risk of having a child with a monogenic disease.
The effectiveness of the PGT-M test has been clearly demonstrated to help limit the situation of babies being born with the disease, limiting the need to terminate the pregnancy midway when the fetus has an abnormal diagnosis. With dangerous genetic diseases, the implementation of prenatal genetic screening and diagnosis is no longer an individual affair of a family, but a long-term step with the contribution of society in general and the medical profession. economy in particular.
For the purpose of improving, improving the quality of the race, and the prosperity of society, PGT-M will improve the status of children born with birth defects, serious genetic diseases and non-reproductive abnormalities. desired in couples.

5. GENTIS - Comprehensive gene ecosystem for Vietnamese people

With the desire to bring the best fertility support methods to doctors and patients in Vietnam, GENTIS has constantly researched, developed, and applied the PGT-M test in preimplantation embryo screening with rare diseases. Not only effective in diagnosing Thalassemia, PGT-M technique also helps diagnose many other rare genetic diseases of embryos such as myelodysplasia, Duchenne muscular dystrophy, hemophilia, osteochondrotic dysplasia. , congenital adrenal hyperplasia, hemophagocytic syndrome, marfan syndrome, autosomal dominant polycystic kidney, iris defect, congenital hearing loss, RETT syndrome,...
At GENTIS, along with the application of new technical technologies, using modern machinery systems (new generation DNA sequencing system NGS Illumina - USA, Veriseq PGS technology) and specialized analysis software Using (STR, SNP analytical methods), the PGT-M test was developed and performed rigorously to provide the most reliable results.

Combining PGT-M screening for single-gene genetic disease with PGT-A screening for aneuploidy embryos will help couples select embryos that do not carry genetic abnormalities to be screened for embryo transfer. With modern technology increasingly developed, GENTIS hopes to deploy, research, and successfully test many other rare genetic diseases, contributing to the successful preimplantation screening process and healthy babies for every family.
With a system of 2 laboratories meeting ISO 9001:2015, ISO 15189:2012 and the ability to perform tens of thousands of tests per year, GENTIS always aims to develop gene technology suitable for Vietnamese people, bringing has great value in the diagnosis, treatment of diseases and assisted reproduction. In particular, GENTIS is increasingly asserting its outstanding position in the field of genetic analysis, maintaining full trust for customers and partners.

[content_more] => [meta_title] => Significance and importance of PGT-M for families with genetic diseases to have healthy children [meta_description] => [meta_keyword] => [thumbnail_alt] => [post_id] => 1097 [category_id] => 4 ) [5] => stdClass Object ( [id] => 1094 [id_crawler] => [category_product] => NULL [thumbnail] => top10_thuong_hieu_uy_tin_chau_a/kait0641.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2023-05-29 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-06-02 14:54:40 [updated_time] => 2023-08-22 15:49:36 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 0 [language_code] => en [slug] => gentis-tiep-tuc-vinh-danh-top-10-thuong-hieu-uy-tin-hang-dau-chau-a-2023 [title] => GENTIS continues to be honored "TOP 10 PRESTIGE BRAND IN ASIA 2023" [description] => Following the title of Top 5 Vietnamese Brands received in December 2022, GENTIS affirms its brand in the medical field not only in Vietnam but also reaching out to Asia with the "TOP 10 TRADE" certification. THE LEADING PRESTIGE BRANDS in Asia 2023". [content] =>

Genetic Analysis Services Joint Stock Company (GENTIS) is a pioneer in the field of genetic analysis in Vietnam, providing solutions and tests in many fields such as reproductive support, obstetrics and gynecology. , gynecology, paediatrics, DNA testing...
Over 13 years of establishment, GENTIS company has grown strongly with outstanding reputation and quality, including 2 international standard testing offices in Hanoi and Ho Chi Minh City and more than 50 sampling points nationwide. GENTIS has become a reliable service provider for nearly 300,000 customers, 12 foreign partners and more than 100 partners who are major hospitals in Vietnam.

On May 27, GENTIS Company was honored to receive the title "TOP 10 PRESTIGE BRAND IN ASIA 2023" - ASIA's TOP TRUSTED BRAND AWARDS 2023 in the announcement ceremony taking place at the Military Theater (HCMC). The award is evaluated by the Asian Business Development Research Center in collaboration with international organizations based on brand evaluation criteria.
From thousands of applications from businesses, the Appraisal Council has screened and selected over 100 typical business brands that are highly appreciated and trusted by the consumer community. After a close and rigorous voting period, GENTIS company excelled in the TOP 10 when meeting the following criteria:
• Being a prestigious and leading brand in the Asian market
• Quality products and services in Vietnam and export to Asia market
• Sustainable development strategy in the Asian market
• Important contribution to the regional economy
• Social responsibility, community
• Comply with regulations on Environment, Customs, Tax, etc.
• Registering for trademark protection in Vietnam and Asian markets
In addition, the Voting Council also evaluates other specific criteria of the company such as: Capacity; Management philosophy; Technological - creative activities; Financial capacity; Human Resources; Marketing strategy;…
As a certificate of these achievements, GENTIS Company has deservedly received the award "TOP 10 PRESTIGE BRAND IN ASIA 2023", a prestigious title for businesses with the leading brand not only in Vietnam but also reaching out to Asia.

Representative of GENTIS company receiving the trophy and certificate of Asia's leading prestigious brand 2023

GENTIS - Bringing a comprehensive genetic ecosystem to Vietnamese people

With a long history of construction and development, GENTIS Company has constantly grown and risen to occupy a pioneering position in the field of genetic analysis and molecular biology. Predecessor from the Center for DNA Sequentialing and Testing, GENTIS has expanded over time to hundreds of other services in the fields of assisted reproduction, obstetrics, paediatrics, gynecology, and immunohematology. …, ready to provide a comprehensive genetic ecosystem for Vietnamese people:

  1. • Adult, premarital testing: HPV-Eprep Cervical Cancer Screening; Pre-marital examination package; Testing for Thalassemia, Thrombophilia, muscular atrophy.
  2. Male and female fertility support test:

- Female: Genetic analysis before PGTest embryo transfer; Analysis of ASEM Test embryo culture environment; Define GENRATEST embryo transfer window; Karyotype Chromosome Test; Antiphospholipid test, NK cells GENNK…
- Men: Sperm DNA fragmentation test; AZF test, anti-sperm antibodies, Sperm aneuploidy, CFTR gene mutation; Testing for sexually transmitted diseases (STDs)…

  1. • Testing for Women to monitor pregnancy: GenEva Advanced Prenatal Screening; Double test & Triple test; Pre-eclampsia testing…
  2. • Testing for Newborns and Children: Newborn screening for common dangerous diseases; Nutrition & allergy testing packages for children; Other Pediatric Tests…
  3. • Testing for Older Adults: Genetic Cancer Genetic Tests; Health test packages: general, cancer screening…

Large scale genetic testing unit in Vietnam

Sharing after the event honoring the Top 10 "Asia's leading prestigious brands", Dr. Pham Dinh Minh - Director of GENTIS Research and Development Center said:
“I am very happy and proud when GENTIS continuously receives the top titles in Vietnam and reaches out to Asia. Overcoming thousands of applications from big and prestigious brands, we were honored to receive this title. This is also the goal of GENTIS in the coming years after joining Eurofins Scientific: Connecting to international integration and cooperating to provide genetic testing services globally.

Dr. Pham Dinh Minh - Director of Research and Development Center of GENTIS . company

As a reputable partner of more than 100 major medical units in the country and gene analysis organizations in the world (Illumina, Qiagen, Sigma, Genoma...), GENTIS is committed to putting the interests of customers and partners first. The first goal is to fulfill the mission of contributing to the physical and intellectual improvement of the Vietnamese people.
After the valuable titles that the company has achieved over the years, GENTIS will strive to achieve even more great success, set a firm footing in the international arena and bring customers, valued Providing the latest services with international standard quality, ensuring the highest accuracy in Vietnam.

[content_more] => [meta_title] => GENTIS continues to be honored "TOP 10 PRESTIGE BRAND IN ASIA 2023" [meta_description] => [meta_keyword] => [thumbnail_alt] => [post_id] => 1094 [category_id] => 4 ) [6] => stdClass Object ( [id] => 1093 [id_crawler] => [category_product] => NULL [thumbnail] => bv_an_duc_thai_binh/dsc09062.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2023-05-15 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-06-02 14:30:19 [updated_time] => 2023-08-22 16:02:25 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 0 [language_code] => en [slug] => gentis-don-vi-dong-hanh-chinh-thuc-tai-hoi-thao-khoa-hoc-benh-vien-phu-san-an-duc [title] => GENTIS: Official companion at the Scientific Conference of An Duc Obstetrics and Gynecology Hospital [description] => On the morning of May 13, 2023, An Duc Obstetrics and Gynecology Hospital held a Scientific Conference on Infertility - Obstetrics and Gynecology with the theme "After 1 year of IVF" in ThaiBinh City. GENTIS Company is honored to be the main partner of the program. [content] =>

The scientific conference Infertility - Obstetrics and Gynecology Thai Binh ended successfully and left a deep impression on doctors and specialists in the field of obstetrics and gynecology across the country. Participating in the program were the leadership of An Duc Obstetrics and Gynecology Hospital: Dr. Doan Duy Manh - Director of the Hospital; Dr. CCII Phan Quang Mac, Deputy Director of the Hospital; Dr. Do Thi Ha - Head of IVF Lab; Dr. Doan Van Khu - Head of An Duc IVF Center;... and representatives from Tu Du Hospital: Dr. Nguyen Tran Quoc Hai; MSc. Nguyen Thien Thuc…

The conference is a special occasion to look back on 8 years of establishment and development of An Duc Obstetrics and Gynecology Hospital and celebrate 1 year of operation of An Duc IVF Center (IVF An Duc). Currently, An Duc Obstetrics and Gynecology Hospital is the first fertility support unit in Thai Binh and neighboring provinces. A special feature is that An Duc IVF Center is invested with a European standard equipment system and gathers a team of leading experts in the field of infertility and infertility.
With high professional competence and warm hearts of medical staff, An Duc IVF Center is a reliable address where infertile couples have access to the best infertility treatments. Therefore, infertile couples can give their full trust on the journey to find their beloved child.

The seminar attracted the attention and attention of nearly 400 obstetricians from many provinces and cities across the country. At the Conference, many reports and lively discussions on the topic of Obstetrics and Gynecology and reproductive support were shared such as:
• Report of 8 years and a journey of An Duc An Duc Obstetrics and Gynecology Hospital - Doctor of CKII Phan Quang Mac, Deputy Director of An Duc PS Hospital
• IVF An Duc 1 year looking back to reach further - Embryologist, Doctor Do Thi Ha, Head of IVF An Duc Lab
• Summary report of Center for Reproductive Support at An Duc Hospital - Dr. Doan Van Khu, Head of An Duc IVF Center
• Fertility support, short-term and long-term outcomes - Dr. Nguyen Tran Quoc Hai, Tu Du Hospital
• Discussion on the issue of How people can access IVF at PS An Duc Thai Binh Hospital and professional cooperation with Tu Du Hospital - MSc. Nguyen Thien Thuc, Deputy Head of Tu Du Hospital's lab

Summing up the scientific conference, Dr. Doan Duy Manh - Director of An Duc Obstetrics and Gynecology Hospital gave a speech on the professional operation of the hospital. At the same time, it affirms that the technique of specialized obstetrics and gynecology and reproductive support at An Duc Hospital is well-invested, methodical, and has been transferred from major units such as the National Hospital of Obstetrics and Gynecology, the Tu Du hospital.
In the future, An Duc Obstetrics and Gynecology Hospital will continue to implement infertility treatment by surgical methods, and focus on the effectiveness of assisted reproductive treatment, individualization of treatment regimens, etc.

In the past time, the development of An Duc IVF Center could not be without the companionship of high-tech genetic testing units. As a partner accompanying An Duc Obstetrics and Gynecology Hospital, GENTIS is honored to provide and sponsor tests in the field of assisted reproductive technology such as:
• Karyotype test: diagnosing chromosomal abnormalities to determine the cause of miscarriage, infertility, and infertility
• FSH receptor gene polymorphism test: determine the cause of poor ovarian response, evaluate cases with high risk of ovarian hyperstimulation.
In addition, GENTIS also provides many tests in the field of assisted reproduction, obstetrics and gynecology such as: Pre-implantation genetic analysis PGTest, Analysis of embryo culture environment ASEM test, Determination of GENRATEST embryo transfer window , Screening for birth defects NIPT-GENEVA, Testing for Thalassemia, Thrombophilia,...

It is hoped that the tests that GENTIS sent to An Duc Obstetrics and Gynecology Hospital in particular and fertility support centers across the country will provide maximum support for doctors and specialists in diagnosis and assisted reproductive treatment, obstetrics and gynecology.
The end of the seminar left an unforgettable impression with the entire leadership, staff at An Duc Hospital for Obstetrics and Gynecology, as well as specialists from all over the country who came to participate. Hopefully in the future, An Duc Obstetrics and Gynecology Hospital will continue to cooperate with GENTIS to improve service quality and bring complete happiness to infertile couples in Thai Binh, as well as neighboring provinces.

[content_more] => [meta_title] => GENTIS: Official companion at the Scientific Conference of An Duc Obstetrics and Gynecology Hospital [meta_description] => [meta_keyword] => [thumbnail_alt] => [post_id] => 1093 [category_id] => 4 ) [7] => stdClass Object ( [id] => 1092 [id_crawler] => [category_product] => NULL [thumbnail] => gentis-cho-con-khoi-dau-ven-toan-bv-thanh-nhan.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2023-05-30 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-05-30 08:45:59 [updated_time] => 2023-08-22 16:21:07 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => gentis-dong-hanh-cung-chuong-trinh-cho-con-yeu-khoi-dau-ven-toan-tai-bv-thanh-nhan [title] => GENTIS accompanies the program "Give your baby a perfect start" at Thanh Nhan Hospital [description] => From June 1, 2023 - July 1, 2023, GENTIS is pleased to accompany the program "Give your baby a perfect start" at the Department of Obstetrics and Gynecology 2 - Thanh Nhan Hospital. This is a program dedicated to pregnant women with the desire to join hands to improve the quality of the population in Vietnam. GENTIS is honored to be the main sponsor of the program. [content] =>

According to statistics from the General Department of Population and Family Planning, in Vietnam each year, more than 1 million children are born, of which about 22,000 to 30,000 children have birth defects. With good prenatal and neonatal screening and diagnosis, about 1,700 children with severe congenital hemolytic anemia (Thalassaemia), 1,400 children with Down syndrome, 500 children with neural tube defects, 200 children with hypothyroidism congenital condition, 10,000 to 20,000 children have G6DP deficiency and many other genetic diseases. In addition, there are also about 60% to 70% of malformations, birth defects so far the cause is still unknown.
This is not only a pain for the child but also a burden for the family and the whole society. Therefore, to ensure the future development of the baby, experts and doctors recommend that families perform NBS right from the time the child is born.
NBS is a test to help detect congenital diseases as early as 48 hours after birth, so that timely interventions can be taken to minimize the damage and development of the child. Mothers can rest assured that their babies will be born healthy, free from common or rare birth defects, and help their children grow steadily and healthy in the future.

Understanding the importance of NBS, GENTIS cooperates with Thanh Nhan Hospital to organize the program "Give your baby a FULL START" to accompany doctors and experts to provide comprehensive health care for newborns. . In particular, GENTIS will immediately give 1 baby clothes when customers register for examination and birth at Department of Obstetrics and Gynecology 2 - Thanh Nhan Hospital.

The gift set for the children is a small gift that GENTIS wants to join hands with Thanh Nhan Hospital to gradually popularize NBS testing more widely to the people of Vietnam. Above all, GENTIS currently offers a variety of NBS test packages for common and common congenital diseases as well as metabolic disorders, giving postpartum mothers the right choice for each person.

GENTIS hopes that the program "Give your baby a perfect start" will contribute to creating human values for babies, with the goal of early screening for abnormal problems that may affect the development. children, help prevent complications, help children develop normally both physically and mentally. At the same time, contributing to the sustainable and strong development of the NBS segment in our country.

Let's update more information about the program "Give your baby a perfect start" at GENTIS Website and Fanpage!

[content_more] => [meta_title] => GENTIS accompanies the program "Give your baby a perfect start" at Thanh Nhan Hospital [meta_description] => [meta_keyword] => [thumbnail_alt] => [post_id] => 1092 [category_id] => 4 ) )

GENTIS receives a delegation of Auditors to monitor and expand ISO 15189:2012

On July 10 - 12, 2023, GENTIS was honored to welcome a delegation of Auditors from the Office of Quality Accreditation (BoA) to conduct the NIPT test monitoring assessment and the criteria to expand the package. NIPT tests (such as PGT-A, Thalassemia, ...) according to ISO 15189:2012 for GENTIS International Laboratories. This event marked the development of the capacity and quality assurance management system in GENTIS testing operations.

GENTIS accompanies the July Prenatal Class at Lac Viet Friendship Hospital

On the morning of July 9, GENTIS and Lac Viet Friendship Hospital jointly organized an extremely meaningful July antenatal class with the theme: "Common problems of postpartum women - Recognizing and handling ". The class has brought pregnant mothers useful and practical knowledge after giving birth.

GENTIS gives 100 gifts to pregnant mothers in the program "Give your baby a perfect start" at Thanh Nhan Hospital

The program "Give your baby a perfect start" took place from June 1, 2023 - July 1, 2023, organized by GENTIS in collaboration with the Department of Obstetrics and Gynecology 2 - Thanh Nhan Hospital and successfully took place. GENTIS is honored to be the main sponsor, accompanying this program.

GENTIS participates in the 2023 National Congress of Obstetrics and Gynecology (VAGO)

The 2023 National Congress of Obstetrics and Gynecology is a major annual event of the Vietnamese health sector, organized by the Vietnam Association of Obstetricians and Gynecologists (VAGO). The conference took place on the morning of June 15, 2023, attracting the participation of more than 500 national and international experts in obstetrics and gynecology, leading clinicians and technical experts. GENTIS is honored to provide the report data to MSc Nguyen Viet Quang (Director of the Center for Reproductive Support of the National Hospital of Obstetrics and Gynecology) with the topic: “Personalization and Optimization of the Embryo Transfer Window: ROLE SUPPORT OF GENE TESTING AND EFFICIENCY IN CLINICAL APPLICATION”.

Significance and importance of PGT-M for families with genetic diseases to have healthy children

PGT-M is a test to detect genetic mutations that cause disease in embryos that are inherited from one parent or both parents before being selected for transfer into the uterus - a method to help mothers with in vitro fertilization (IVF) give birth to a healthy baby. Thereby improving the quality of embryo transfer and giving birth to healthy babies.

GENTIS continues to be honored "TOP 10 PRESTIGE BRAND IN ASIA 2023"

Following the title of Top 5 Vietnamese Brands received in December 2022, GENTIS affirms its brand in the medical field not only in Vietnam but also reaching out to Asia with the "TOP 10 TRADE" certification. THE LEADING PRESTIGE BRANDS in Asia 2023".

GENTIS: Official companion at the Scientific Conference of An Duc Obstetrics and Gynecology Hospital

On the morning of May 13, 2023, An Duc Obstetrics and Gynecology Hospital held a Scientific Conference on Infertility - Obstetrics and Gynecology with the theme "After 1 year of IVF" in ThaiBinh City. GENTIS Company is honored to be the main partner of the program.

GENTIS accompanies the program "Give your baby a perfect start" at Thanh Nhan Hospital

From June 1, 2023 - July 1, 2023, GENTIS is pleased to accompany the program "Give your baby a perfect start" at the Department of Obstetrics and Gynecology 2 - Thanh Nhan Hospital. This is a program dedicated to pregnant women with the desire to join hands to improve the quality of the population in Vietnam. GENTIS is honored to be the main sponsor of the program.
ĐĂNG KÝ DỊCH VỤ TẠI GENTIS
Cảm ơn Quý khách đã tin tưởng sử dụng dịch vụ của GENTIS,
Quý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!